BAY987521
BAY987521 is a pharmaceutical drug with 12 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
83.3%
10 of 12 finished
16.7%
2 ended early
0
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sun Protection Factor Assay (SPF Assay 204/2016)
Sun Protection Factor Assay (SPF Assay 206/2016)
Sun Protection Factor Assay (SPF Assay 207/2016)
Sun Protection Factor Assay (SPF Assay 205/2016)
Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes
Clinical Trials (12)
Sun Protection Factor Assay (SPF Assay 204/2016)
Sun Protection Factor Assay (SPF Assay 206/2016)
Sun Protection Factor Assay (SPF Assay 207/2016)
Sun Protection Factor Assay (SPF Assay 205/2016)
Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes
18475 - Sun Protection Factor Assay
Sun Protection Factor Assay (319/2016)
Sun Protection Factor Assay (317/2016)
Sun Protection Factor Assay (344/2016)
Sun Protection Factor Assay (338/2016)
Sun Protection Factor Assay (318/2016)
Sun Protection Factor Assay (343/2016)
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12